AB
TPTX

Amalgamated Bank’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Amalgamated Bank’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,968
Closed -$449K – 3008
2022
Q2 		$449K Buy
5,968
+203
+4% +$9.02K ﹤0.01% 1513
2022
Q1 		$155K Sell
5,765
-432
-7% -$14.5K ﹤0.01% 2036
2021
Q4 		$296K Sell
6,197
-64
-1% -$2.86K ﹤0.01% 1829
2021
Q3 		$416K Sell
6,261
-444
-7% -$31.6K ﹤0.01% 1683
2021
Q2 		$523K Buy
6,705
+1,527
+29% +$113K ﹤0.01% 1618
2021
Q1 		$490K Sell
5,178
-460
-8% -$54.7K 0.02% 994
2020
Q4 		$687K Buy
5,638
+523
+10% +$57.3K 0.03% 781
2020
Q3 		$447K Buy
5,115
+800
+19% +$55.7K 0.02% 905
2020
Q2 		$279K Sell
4,315
-562
-12% -$32.4K 0.01% 1150
2020
Q1 		$218K Sell
4,877
-91
-2% -$4.83K 0.01% 1315
2019
Q4 		$309K Buy
+4,968
New +$236K 0.01% 1389

Amalgamated Bank's TPTX Position: Q3 2022 in Review

Amalgamated Bank sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 5,968 shares — an estimated $449K sold.

Amalgamated Bank first reported a position in TPTX in Q4 2019 and held it in 11 quarters. The position peaked at $687K in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Amalgamated Bank reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Amalgamated Bank sold 5,968 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $449K.
  • Amalgamated Bank first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
  • Amalgamated Bank's Turning Point Therapeutics, Inc. Common Stock position peaked at $687K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Amalgamated Bank's 13F filing for Q3 2022, filed 9 Nov 2022.